Correlation of antibiotic-induced endotoxin release and cytokine production in Escherichia coli-inoculated mouse whole blood ex vivo.

Escherichia coli were incubated in mouse whole blood ex vivo supplemented with beta-lactam antibiotics that possessed preferential affinities for penicillin-binding proteins (PBPs). After 4 h, viable bacteria were undetectable in the presence of any of the 3 antibiotics tested, whereas significant increases in colony-forming units were detected in samples not treated with antibiotics. Differential levels of endotoxin in platelet-rich plasma were detected using the limulus amebocyte lysate assay, according to differential antibiotic affinities for the various PBPs. Levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in antibiotic-treated cultures after 8 h of incubation correlated well with the levels of endotoxin at 4 h (r = .96, P < .0001 for TNF-alpha; r = .91, P = .0002 for IL-6). These data indicate that differential affinities of beta-lactam antibiotics for PBPs affect both endotoxin and cytokine responses ex vivo in mouse blood and correlate with in vivo protective efficacy of these antibiotics in gram-negative experimental models.

[1]  A. Shigematsu,et al.  Contribution of neutrophils to lipopolysaccharide-induced tumor necrosis factor production and mortality in a carrageenan-pretreated mouse model. , 1997, FEMS immunology and medical microbiology.

[2]  S. Opal,et al.  The in vivo significance of antibiotic-induced endotoxin release in experimental Gram-negative sepsis , 1996 .

[3]  J. Jackson,et al.  Differences in mode of action of (β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy , 1996 .

[4]  R. Maier,et al.  The clinical significance of endotoxin released by antibiotics: what is the evidence? , 1996 .

[5]  A. Dofferhoff,et al.  The influence of antibiotic-induced filament formation on the release of endotoxin from Gram-negative bacteria , 1996 .

[6]  T. Kirikae,et al.  Biological characterization of Pseudomonas aeruginosa endotoxin released by antibiotic treatment in vitro , 1996 .

[7]  S. Bucklin,et al.  Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. , 1995, The Journal of infectious diseases.

[8]  E. Kuijper,et al.  Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. , 1995, The Journal of infectious diseases.

[9]  Y. Sumita,et al.  Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3. , 1995, The Journal of antimicrobial chemotherapy.

[10]  S. Deventer,et al.  Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum , 1995, Infection and immunity.

[11]  M. Leeson,et al.  INDUCTION OF PROINFLAMMATORY RESPONSES IN HUMAN MONOCYTES BY PARTICULATE AND SOLUBLE FORMS OF LIPOPOLYSACCHARIDE , 1994, Shock.

[12]  S. Deventer,et al.  Clinical relevance of antibiotic-induced endotoxin release , 1994, Antimicrobial Agents and Chemotherapy.

[13]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[14]  J. Hurley,et al.  Antibiotic-induced release of endotoxin: a reappraisal. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. Hopkin.  FRAPPER FORT OU FRAPPER DOUCEMENT: A GRAM-NEGATIVE DILEMMA , 1978, The Lancet.

[16]  R. Yogev,et al.  Antibiotic-Induced Bacterial Killing Stimulates Tumor Necrosis Factor-α Release in Whole Blood , 1993 .

[17]  D. C. Morrison,et al.  Endotoxins and disease mechanisms. , 1987, Annual review of medicine.

[18]  M Tuszkiewicz,et al.  [Bacterial endotoxins]. , 1967, Polski tygodnik lekarski.